Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
ES14 - What First Line in Oncogene Addicted NSCLC
- 15:15 - 16:45
- 9/08/2019
- Location: Vancouver (2003)
- IASLC CME Accredited
- Type: Educational Session
- Track: Targeted Therapy
- Moderators:Dolores Isla, Jessica Menis
-
+
ES14.05 - Patients Harbouring a Driven-Mutation: Pro and Patient's Perspective
16:15 - 16:30 | Presenter: Karen L Reckamp
- Abstract
Loading...
-
+
P1.01 - Advanced NSCLC
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Advanced NSCLC
-
+
P1.01-105 - US Real-World Management of EGFR-Mutated Advanced NSCLC: Prescribing and Attrition Data from First-To-Second-Line Treatment
09:45 - 09:45 | Presenter: Karen L Reckamp | Author(s): Jorge Nieva, Aliki Taylor, Bharat Thakrar, Jennifer L Wong, Danielle Potter, Nicolaas A. Bakker, Wendy S Rubinstein, Ping Sun
- Abstract
Loading... -
+
P1.01-67 - Ph I/II Carboplatin, Nab-Paclitaxel and Pembrolizumab for Advanced NSCLC (HCRN LUN13-175): Outcomes by Nab-Paclitaxel Dose
09:45 - 09:45 | Presenter: Ryan D Gentzler | Author(s): Nisha Anjali Mohindra, Shadia I Jalal, Karen L Reckamp, Richard D Hall, Nasser Hanna, Young Kwang Chae, Victoria Meucci Villaflor, Marianna Koczywas, Irene B Helenowski, Alfred W Rademaker, Jyoti D Patel
- Abstract
Loading... -
+
P1.01-96 - US Real-World Management of EGFR-Mutated Advanced NSCLC: Survival After First-Line EGFR-Tyrosine Kinase Inhibitor Treatment
09:45 - 09:45 | Presenter: Jorge Nieva | Author(s): Karen L Reckamp, Aliki Taylor, Bharat Thakrar, Jennifer L Wong, Danielle Potter, Nicolaas A. Bakker, Wendy S Rubinstein, Ping Sun
- Abstract
Loading...
-
+
P1.14 - Targeted Therapy
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Targeted Therapy
-
+
P1.14-27 - Duration of Targeted Therapy in Advanced NSCLC (aNSCLC) with Drivers Identified by Circulating Tumor DNA (ctDNA) Analysis
09:45 - 09:45 | Presenter: Christina Baik | Author(s): Tejas Patil, Kedar Kirtane, Rafael Santana-Davila, Thereasa Rich, Carin Espenschied, Caroline Weipert, Stephanie Mach, Karen L Reckamp, Robert C. Doebele
- Abstract
Loading... -
+
P1.14-32 - Rash and Efficacy in Anaplastic Lymphoma Kinase Positive (ALK+) Non-Small Cell Lung Cancer Patients Treated with Ensartinib
09:45 - 09:45 | Presenter: Heather A Wakelee | Author(s): Karen L Reckamp, Ticiana A. Leal, Alberto Chiappori, Saiama Waqar, Karen Zeman, Joel W Neal, Chris Liang, Kim Harrow, Allison Holzhausen, Joey Zhou, Giovanni Selvaggi, Leora Horn
- Abstract
Loading...
-
+
P1.18 - Treatment of Locoregional Disease - NSCLC
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Treatment of Locoregional Disease - NSCLC
-
+
P1.18-05 - ChemoXRT W/ Consolidation Pembrolizumab in Unresectable Stage III NSCLC: Long-Term Survival Update and Analysis of Post-Progression Therapy
09:45 - 09:45 | Presenter: Greg Durm | Author(s): Sandra Althouse, Ahad Sadiq, Shadia I Jalal, Salma Jabbour, Robin Zon, Goetz H. Kloecker, Michael Williamson, Karen L Reckamp, Ebenezer Kio, Robert Langdon, Bamidele Adesunloye, Ryan D Gentzler, Wael Harb, Radhika Walling, Christina Yeon, Marianna Koczywas, Nasser Hanna
- Abstract
Loading...
-
+
PL02 - Presidential Symposium including Top 7 Rated Abstracts
- 08:00 - 10:15
- 9/09/2019
- Location: Barcelona (2005)
- IASLC CME Accredited
- Type: Plenary Session
- Track:
- Moderators:Giorgio Vittorio Scagliotti, Ramon Rami-Porta
-
+
PL02.08 - Registrational Results of LIBRETTO-001: A Phase 1/2 Trial of LOXO-292 in Patients with RET Fusion-Positive Lung Cancers
09:10 - 09:20 | Presenter: Alexander Drilon | Author(s): Geoffrey R Oxnard, Lori Wirth, Benjamin Besse, Oliver Gautschi, Shao Weng Daniel Tan, Herbert H. Loong, Todd Bauer, Yu Jung Kim, Atsushi Horiike, Keunchil Park, Manisha Shah, Caroline McCoach, Lyudmila Bazhenova, Takashi Seto, Marcia Brose, Nathan Pennell, Jared Weiss, Ignacio Matos, Nir Peled, Byoung Chul Cho, Yuichiro Ohe, Karen L Reckamp, Valentina Boni, Miyako Satouchi, Gerald S Falchook, Wallace Akerley, Haruko Daga, Tomohiro Sakamoto, Jyoti D Patel, Nehal Lakhani, Fabrice Barlesi, Mark Burkard, Viola W. Zhu, Victor Moreno, Jacques Medioni, Marc Matrana, Christian Rolfo, Dae Ho Lee, Hovav Nechushtan, Melissa Johnson, Vamsidhar Velcheti, Makoto Nishio, Ryo Toyozawa, Kadoaki Ohashi, Lucy Song, Ji-Youn Han, Alexander Spira, Filippo Guglielmo Maria De Braud, Kristoffer Staal Rohrberg, Shinji Takeuchi, Jun Sakakibara-Konishi, Saiama Waqar, Hirotsugu Kenmotsu, Frederick Wilson, Binoj Nair, Elizabeth Olek, Jennifer Kherani, Kevin Ebata, Edward Zhu, Michele Nguyen, Luxi Yang, Xin Huang, Scott Cruickshank, Stephen Michael Rothenberg, Benjamin J Solomon, Koichi Goto, Vivek Subbiah
- Abstract
Loading...
-
+
MA13 - Going Back to the Roots!
- 14:00 - 15:30
- 9/09/2019
- Location: Vancouver (2003)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Advanced NSCLC
- Moderators:Maurice Perol, Kaoru Kubota
-
+
MA13.08 - Discussant - MA13.05, MA13.06, MA13.07
14:45 - 15:00 | Presenter: Karen L Reckamp
- Abstract
No abstract available for this presentation
-
+
P2.04 - Immuno-oncology
- 10:15 - 18:15
- 9/09/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Immuno-oncology
-
+
P2.04-88 - Surgical Outcomes of a Multicenter Phase II Trial of Neoadjuvant Atezolizumab in Resectable Stages IB-IIIB NSCLC: Update on LCMC3 Clinical Trial
10:15 - 10:15 | Presenter: Jay M Lee | Author(s): Jamie E. Chaft, Alan Nicholas, G Alec Patterson, Saiama Waqar, ERIC M Toloza, Eric B Haura, DAN J Raz, Karen L Reckamp, ROBERT E Merritt, Dwight Hall Owen, DAVID J Finley, CIARAN J McNamee, Justin D Blasberg, Edward Garon, JOHN D Mitchell, Robert C. Doebele, FRANK A Baciewicz, Misako Nagasaka, Harvey I Pass, Ann Johnson, See-Chun Phan, Katja Schulze, Paul A Bunn, Jr, Bruce E Johnson, Mark G Kris, David J Kwiatkowski, Ignacio Wistuba, David P Carbone, Valerie W. Rusch
- Abstract
Loading...
-
+
OA13 - Ideal Approach to Lung Resection and Novel Perioperative Therapy
- 11:30 - 13:00
- 9/10/2019
- Location: Toronto (1985)
- IASLC CME Accredited
- Type: Oral Session
- Track: Treatment of Early Stage/Localized Disease
- Moderators:Tomasz Grodzki, Kenji Suzuki
-
+
OA13.07 - Neoadjuvant Atezolizumab in Resectable NSCLC Patients: Immunophenotyping Results from the Interim Analysis of the Multicenter Trial LCMC3
12:30 - 12:40 | Presenter: Filiz Oezkan | Author(s): Kai He, Dwight Hall Owen, Maciej Pietrzak, Ju Hwan Cho, Rhonda Kitzler, Rebecca Pearson, Valerie W. Rusch, Jamie E. Chaft, Robert Suh, Justin D Blasberg, Karen L Reckamp, Dan J Raz, Peter J Kneuertz, Lauren Fiorillo, Edward Garon, Alan Nicholas, Ann Johnson, Katja Schulze, Jessica Grindheim, Romain Banchereau, See-Chun Phan, Paul A Bunn, Jr, David J Kwiatkowski, Bruce E Johnson, Mark G Kris, Ignacio Wistuba, Jay M Lee, Gerard Lozanski, David P Carbone
- Abstract
Loading...